bluebird bio Inc (LTS:0HOH)
$ 0.5004 0.0109 (2.23%) Market Cap: 96.39 Mil Enterprise Value: 342.75 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 29/100

bluebird bio Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 04, 2020 / 07:30PM GMT
Release Date Price: $61.77
Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Good afternoon, everyone. This is Biren Amin. I want to welcome everyone to the Jefferies Healthcare Conference. I would like to introduce our next company, bluebird bio. This is a fireside chat format with Nick Leschly, bluebird's CEO; Dave Davidson, bluebird's Chief Medical Officer; and Chip Baird, bluebird's Chief Financial Officer. If anyone in the audience would like to ask questions, they can e-mail me at [email protected].

So welcome, bluebird team. It's great to have you on.

Questions & Answers

Biren N. Amin
Jefferies LLC, Research Division - MD and Senior Equity Research Analyst

Maybe we could get started with, a few weeks ago, you unveiled a cost-saving strategy. Can we maybe, I guess, start with what drove that and whether you feel you've optimized your operating plan with the announcement of that strategy?

Nick Leschly
bluebird bio, Inc. - President, CEO & Director

Yes. This is Nick Leschly

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot